Posted as supplied by author.

w1. Geddes JR and Cipriani A. Selective serotonin reuptake inhibitors. Remain useful drugs which need careful monitoring. BMJ 2004;329;809-10.

w2. Cipriani A, Barbui C,Geddes JR. Suicide, depression and antidepressants. BMJ 2005 ; 330; 373-4

w3 Report of the CSM Expert Working Group on the safety of selective serotonin reuptake inhibitors. 2004. www.mhra.gov.uk/news/2004/SSRIfinal.pdf (accessed 22 Mar 2005).

w4 National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care. Clinical Guideline 23. London: NICE, 2004. www.nice.org.uk/pdf/CG023quickrefguide.pdf (accessed 22 Mar 2005)

w5 Fast-forwarding primary care mental health: Graduate primary care mental health workers - best practice guidance. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4005784&chk=5cCbHf (accessed 22 Mar 2005)

w6 The new general medical services contract, British Medical Association.

(www.bma.org.uk/ap.nsf/Content/__Hub�GPC�contract) (accessed 22 Mar 2005)

�